James E Dalen. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » Anticoagulants/administration & dosageAnticoagulants/adverse effectsFemaleHeparin/administration & dosageHeparin/adverse effectsHumansMalePrognosisPulmonary Embolism/drug therapyPulmonary Embolism/mortalityRandomized Controlled Trials as TopicRisk AssessmentSensitivity and SpecificitySurvival AnalysisThrombolytic Therapy/adverse effectsThrombolytic Therapy/methodsTreatment Outcome
Substances: See more » AnticoagulantsHeparin
Year: 2002 PMID: 12456222 DOI: 10.1001/archinte.162.22.2521
Source DB: PubMed Journal: Arch Intern Med ISSN: 0003-9926